Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Spiegelman Daniel K
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   155,668    

Indirect Shares

   6,673      
Direct Value   $5,250,478    

Indirect Value

   $0      
Total Shares   162,341      
Total Value   $5,250,478      


CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $1,024,068 CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $1,024,068
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            CV Therapeutics Inc CVTX SVP, CFO 2009-04-09 67,489 2009-04-09 6,673    Premium*  
            Cascadian Therapeutics, Inc CASC Director 2018-03-09 0 2009-12-04 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Financial O... 2019-04-30 47,686 2012-05-29 0    Premium*  
            Relypsa Inc RLYP Director 2016-09-01 0 2015-06-04 0    Premium*  
            Myriad Genetics Inc MYGN Director 2023-06-02 40,493 2020-05-27 0    Premium*  
* Premium Members only  

Records found :    180         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CASC Cascadian Therapeutics, I... Director   –       •      –    2014-03-11 4 D $3.65 $17,659 D/D (4,838) 38,871 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-04-30 4 A $49.50 $4,653 D/D 94 64,367 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-05-02 4 S $58.02 $644 D/D (11) 68,737 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-05-15 4 D $57.44 $71,283 D/D (1,241) 63,126 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-05-29 4 D $57.50 $218,040 D/D (3,792) 59,334 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-06-04 4 A $0.00 $0 D/D 13,800 73,134 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2014-06-07 4 D $3.06 $6,255 D/D (2,044) 36,827 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-07-02 4 S $64.00 $142,656 D/D (2,229) 70,905 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-08-01 4 S $61.76 $137,652 D/D (2,229) 68,676 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-08-06 4 A $62.17 $870 D/D 14 68,751 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-09-02 4 S $69.83 $1,117,314 D/D (16,000) 68,676 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-09-02 4 OE $39.06 $624,960 D/D 16,000 84,676 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-09-03 4 S $69.70 $1,256 D/D (18) 68,733 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-03-02 4 OE $39.06 $605,430 D/D 15,500 84,176 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-03-02 4 S $107.00 $1,658,500 D/D (15,500) 68,676 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-03-03 4 A $0.00 $0 D/D 10,500 79,278 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2015-03-25 4 B $1.63 $16,271 D/D 10,000 30,644 2.39 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2015-03-26 4 B $1.59 $15,856 D/D 10,000 40,644 2.39 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-04-30 4 A $51.26 $4,511 D/D 88 79,366 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-15 4 D $122.78 $211,427 D/D (1,722) 77,644 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-18 4 AS $130.00 $4,430,140 D/D (34,078) 41,507 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-18 4 S $124.77 $256,905 D/D (2,059) 75,585 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-29 4 D $125.57 $540,579 D/D (4,305) 37,202 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-05-29 4 AS $126.15 $199,065 D/D (1,578) 35,624 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-06-01 4 AS $124.16 $489,811 D/D (3,945) 31,679 0 -
  180  Records found
  1   2   3   4  5   6   7   8      
  Page 4 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us